MT Newswires
Medicenna Says Updated MDNA11 Data Strengthen Consistency of Anti-Tumor Activity
➖
AI Sentiment
Neutral
4/10
Merck & Company Inc. (new) News
Latest updates and market news for MRK
20 news
Dec 4 - Dec 10, 2025
Page 1
MT Newswires
HSBC Adjusts Price Target on Merck & Co. to $120 From $100, Maintains Buy Rating
📊
AI Sentiment
Positive
7/10
Simply Wall St.
Merck (NYSE:MRK) Could Be A Buy For Its Upcoming Dividend
📊
AI Sentiment
Positive
7/10
24/7 Wall St.
Schwab’s SCHD ETF Is Mostly Solid, But 1 Top Holding Is Concerning
📊
AI Sentiment
Positive
7/10
Motley Fool
Here's 1 Major Catalyst Behind Merck Stock's Recent 3.8% Bump
📈
AI Sentiment
Highly Positive
8/10
Motley Fool
1 Major Factor Behind the Healthcare Sector's Recent Surge
📈
AI Sentiment
Highly Positive
8/10
Investor's Business Daily
How Protein And Pets Drove Elanco Animal Health's 79% Gain In 2025
📈
AI Sentiment
Highly Positive
8/10
Business Wire
BenchSci Extends ASCEND Agreement with Merck to Support Preclinical Disease Biology Research
📈
AI Sentiment
Highly Positive
8/10
Business Wire
Ability Biotherapeutics Appoints Angèle Maki, PhD, as Chief Business Officer
📈
AI Sentiment
Highly Positive
9/10
GlobeNewswire
Strategic Pharma Collaborations Propel RCC Market Growth
📈
AI Sentiment
Highly Positive
8/10
Barchart
These 2 High-Yield Dividend Stocks Are Some of the Safest Buys Right Now
📊
AI Sentiment
Positive
7/10
Zacks
Watch 5 Bigwigs in December After Double-Digit Returns Past Month
📈
AI Sentiment
Highly Positive
8/10
CNW Group
Saskatchewan Adds CAPVAXIVE® to Publicly Funded Adult Immunization Program
📈
AI Sentiment
Highly Positive
8/10
PR Newswire
Oppenheimer & Co. Inc. Strengthens Equities and Biotech Research Teams with Addition of Kostas Biliouris, Ph.D.
📈
AI Sentiment
Highly Positive
8/10
Insider Monkey
Jim Cramer on Merck: “The People Who Run This Company Are Not Idiots”
📊
AI Sentiment
Positive
7/10
Motley Fool
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
📊
AI Sentiment
Positive
6/10
Motley Fool
Merck's Stock is Suddenly Soaring, but Is the Struggling Healthcare Giant a Buy?
📊
AI Sentiment
Positive
7/10
Share this news page